Literature DB >> 33650095

Supplementation of the In Vitro Maturation Culture Medium of Mouse Oocytes with Growth Hormone Improves Pregnancy Outcomes.

Caihong Ma1,2, Jinliang Zhu3,4, Yihua Lin5, Bingteng Xie1,2,6,7, Xiaoxue Li1,2,6,7, Rong Li1,2, Jie Qiao1,2,6,7.   

Abstract

This study aimed to examine the effects of adding growth hormone (GH) into the in vitro maturation (IVM) culture medium of mouse oocytes on pregnancy outcomes. Cumulus-oocyte complexes (COCs) were cultured in a medium with (GH group, 100 ng/mL) or without (Con group) GH. Thereafter, chromosome morphology, spindle morphology, and mitochondrial function were examined. Embryo development and blastocyst quality after in vitro fertilization were evaluated. After the embryo transfer, the implantation sites and pregnancy outcomes were evaluated. The oocyte maturation rate of the GH group (81.8 ± 9.6%) was compared to that of the Con group (81.3 ± 6.9%, P = 0.928). The proportion of morphologically abnormal spindles in GH-treated oocytes (7.1 ± 0.9%) was significantly lower than control oocytes (13.7 ± 1.3%, P = 0.032), whereas the proportion of morphologically abnormal chromosomes and mitochondrial distribution was similar between the groups. The mitochondrial membrane potential (P < 0.001) and ATP concentration (P < 0.001) in GH-exposed oocytes were higher than those in control oocytes. After fertilization, the blastocyst rate in the GH group (33.8 ± 13.2%) was significantly higher than the Con group (16.2 ± 2.0%, P = 0.003). In addition, inner cell mass (ICM) number (13.91 ± 3.48 vs. 7.00 ± 1.91, P < 0.001), total cell number (47.45 ± 8.39 vs. 37.71 ± 4.15, P = 0.007), and the ratio of ICM/total cell number (29.9 ± 8.2% vs. 18.6 ± 5.0%, P = 0.002) of blastocyst were all higher in GH group. The implantation rate (71.2 ± 1.9% vs. 39.4 ± 16.4%, P < 0.001) and litter size (8.50 ± 3.99 vs. 3.00 ± 1.22, P = 0.018) were significantly higher in the GH group. Although addition of GH into IVM culture medium does not improve oocyte maturation rate, it improves oocyte and embryo quality, which leads to better embryo development and pregnancy outcomes.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  Embryo development; Growth hormone; In vitro maturation; Oocyte quality; Pregnancy outcome

Mesh:

Substances:

Year:  2021        PMID: 33650095     DOI: 10.1007/s43032-021-00507-4

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  20 in total

1.  Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF.

Authors:  John L Yovich; James D Stanger
Journal:  Reprod Biomed Online       Date:  2010-04-02       Impact factor: 3.828

2.  Critical estradiol dose optimization for oocyte in vitro maturation in the common marmoset.

Authors:  O Y Tkachenko; S Delimitreva; M Heistermann; J U Scheerer-Bernhard; E Wedi; P L Nayudu
Journal:  Theriogenology       Date:  2015-01-16       Impact factor: 2.740

3.  Amphiregulin promotes the maturation of oocytes isolated from the small antral follicles of the rhesus macaque.

Authors:  Marina C Peluffo; Alison Y Ting; Alberuni M Zamah; Marco Conti; Richard L Stouffer; Mary B Zelinski; Jon D Hennebold
Journal:  Hum Reprod       Date:  2012-05-16       Impact factor: 6.918

4.  Effects of combined epidermal growth factor, brain-derived neurotrophic factor and insulin-like growth factor-1 on human oocyte maturation and early fertilized and cloned embryo development.

Authors:  Yang Yu; Jie Yan; Min Li; Liying Yan; Yue Zhao; Ying Lian; Rong Li; Ping Liu; Jie Qiao
Journal:  Hum Reprod       Date:  2012-04-23       Impact factor: 6.918

5.  Clinical definition paper on in vitro maturation of human oocytes.

Authors:  Michael H Dahan; Seang Lin Tan; Jintae Chung; Weon-Young Son
Journal:  Hum Reprod       Date:  2016-05-09       Impact factor: 6.918

6.  In vitro maturation of bovine oocytes in the presence of growth hormone accelerates nuclear maturation and promotes subsequent embryonic development.

Authors:  F Izadyar; B Colenbrander; M M Bevers
Journal:  Mol Reprod Dev       Date:  1996-11       Impact factor: 2.609

7.  Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology.

Authors:  Maryam Eftekhar; Abbas Aflatoonian; Farnaz Mohammadian; Tahereh Eftekhar
Journal:  Arch Gynecol Obstet       Date:  2012-12-04       Impact factor: 2.344

8.  Selection of developmentally competent immature equine oocytes with brilliant cresyl blue stain prior to in vitro maturation with equine growth hormone.

Authors:  Gabriel R Pereira; Pedro L Lorenzo; Gustavo F Carneiro; Sylvie Bilodeau-Goeseels; John P Kastelic; Alejandro Esteller-Vico; Manel Lopez-Bejar; Irwin K M Liu
Journal:  Zygote       Date:  2013-02-01       Impact factor: 1.442

Review 9.  In vitro oocyte maturation: current status.

Authors:  Daniela Nogueira; Jean Clair Sadeu; Jacques Montagut
Journal:  Semin Reprod Med       Date:  2012-05-14       Impact factor: 1.303

10.  Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome.

Authors:  Lan N Vuong; Anh H Le; Vu N A Ho; Toan D Pham; Flor Sanchez; Sergio Romero; Michel De Vos; Tuong M Ho; Robert B Gilchrist; Johan Smitz
Journal:  J Assist Reprod Genet       Date:  2020-01-04       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.